Advanced Therapeutics Pharmaceutical Outsourcing Market

Table of Content

1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand Side Trends
    1.3. Supply-Side Trends
    1.4. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
    2.3. Inclusions and Exclusions
3. Key Market Trends
    3.1. Key Trends Impacting the Market
4. Value Added Insights
    4.1. Service Type Adoption, By Region
    4.2. Overview of CRO and CDMO Services
    4.3. Role of Contract Service Providers
    4.4. Regulatory Scenario, By Country
    4.5. Industry Deals
    4.6. PESTEL Analysis by Region
    4.7. PORTER Analysis
5. Market Background
    5.1. Macro-Economic Factors
        5.1.1. Global Healthcare Expenditure Outlook
        5.1.2. Global Research and Development Funding Outlook
        5.1.3. Global Life Expectancy Outlook
        5.1.4. Global Oncology Spending Outlook
        5.1.5. Growing Geriatric Population
    5.2. Forecast Factors - Relevance and Impact
        5.2.1. Increase in Research and Development Funding and Grants
        5.2.2. Increasing Incidence of Genetic Disorders
        5.2.3. Service Type Pipeline
        5.2.4. Service Type Innovation Trends
        5.2.5. Market Consolidation Activities
        5.2.6. Prevalence of Chronic Diseases
        5.2.7. Shift Towards Technologically Advanced Service Types
    5.3. Market Dynamics
        5.3.1. Drivers
        5.3.2. Restraints
        5.3.3. Opportunity Analysis
6. Global Market Demand (in Value or Size in US$ million) Analysis 2019 to 2023 and Forecast, 2024 to 2034
    6.1. Historical Market Value (US$ million) Analysis, 2019 to 2023
    6.2. Current and Future Market Value (US$ million) Projections, 2024 to 2034
        6.2.1. Y-o-Y Growth Trend Analysis
        6.2.2. Absolute $ Opportunity Analysis
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Service Type
    7.1. Introduction / Key Findings
    7.2. Historical Market Size (US$ million) By Service Type, 2019 to 2023
    7.3. Current and Future Market Size (US$ million) Analysis and Forecast By Service Type, 2024 to 2034
        7.3.1. Contract Research Organizations (CROs)
        7.3.2. Contract Development and Manufacturing Organizations (CDMOs)
    7.4. Market Attractiveness Analysis By Service Type
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
    8.1. Introduction / Key Findings
    8.2. Historical Market Size (US$ million) Analysis By Indication, 2019 to 2023
    8.3. Current and Future Market Size (US$ million) Analysis and Forecast By Indication, 2024 to 2034
        8.3.1. Oncology
        8.3.2. Neurology
        8.3.3. Cardiology
        8.3.4. Infectious Diseases
        8.3.5. Others
    8.4. Market Attractiveness Analysis By Indication
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy
    9.1. Introduction / Key Findings
    9.2. Historical Market Size (US$ million) By Therapy, 2019 to 2023
    9.3. Current and Future Market Size (US$ million) Analysis and Forecast By Therapy, 2024 to 2034
        9.3.1. Cell Therapy
        9.3.2. Gene Therapy
        9.3.3. RNA-based Therapies
        9.3.4. Others
    9.4. Market Attractiveness Analysis By Therapy
10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phases
    10.1. Introduction / Key Findings
    10.2. Historical Market Size (US$ million) By Phases, 2019 to 2023
    10.3. Current and Future Market Size (US$ million) Analysis and Forecast By Phases, 2024 to 2034
        10.3.1. Preclinical Services
        10.3.2. Clinical Services
        10.3.3. Commercial Manufacturing and Packaging
    10.4. Market Attractiveness Analysis By Phases
11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
    11.1. Introduction / Key Findings
    11.2. Historical Market Size (US$ million) Analysis By Region, 2019 to 2023
    11.3. Current and Future Market Size (US$ million) Analysis and Forecast By Region, 2024 to 2034
        11.3.1. North America
        11.3.2. Latin America
        11.3.3. East Asia
        11.3.4. South Asia and Pacific
        11.3.5. Western Europe
        11.3.6. Eastern Europe
        11.3.7. Middle East and Africa
    11.4. Market Attractiveness Analysis By Region
12. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034
    12.1. Introduction
    12.2. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2023
    12.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
        12.3.1. By Country
            12.3.1.1. United States
            12.3.1.2. Canada
            12.3.1.3. Mexico
        12.3.2. By Service Type
        12.3.3. By Indication
        12.3.4. By Therapy
        12.3.5. By Phases
    12.4. Market Attractiveness Analysis
        12.4.1. By Country
        12.4.2. By Service Type
        12.4.3. By Indication
        12.4.4. By Therapy
        12.4.5. By Phases
    12.5. Country Level Analysis and Forecast
        12.5.1. United States Market Analysis
            12.5.1.1. Introduction
            12.5.1.2. Market Analysis and Forecast by Market Taxonomy
                12.5.1.2.1. By Service Type
                12.5.1.2.2. By Indication
                12.5.1.2.3. By Therapy
                12.5.1.2.4. By Phases
        12.5.2. Canada Market Analysis
            12.5.2.1. Introduction
            12.5.2.2. Market Analysis and Forecast by Market Taxonomy
                12.5.2.2.1. By Service Type
                12.5.2.2.2. By Indication
                12.5.2.2.3. By Therapy
                12.5.2.2.4. By Phases
        12.5.3. Mexico Market Analysis
            12.5.3.1. Introduction
            12.5.3.2. Market Analysis and Forecast by Market Taxonomy
                12.5.3.2.1. By Service Type
                12.5.3.2.2. By Indication
                12.5.3.2.3. By Therapy
                12.5.3.2.4. By Phases
13. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034
    13.1. Introduction
    13.2. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2023
    13.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
        13.3.1. By Country
            13.3.1.1. Brazil
            13.3.1.2. Chile
            13.3.1.3. Rest of Latin America
        13.3.2. By Service Type
        13.3.3. By Indication
        13.3.4. By Therapy
        13.3.5. By Phases
    13.4. Market Attractiveness Analysis
        13.4.1. By Country
        13.4.2. By Service Type
        13.4.3. By Indication
        13.4.4. By Therapy
        13.4.5. By Phases
    13.5. Market Trends
    13.6. PESTEL Analysis
    13.7. Key Market Participants - Intensity Mapping
    13.8. Drivers and Restraints - Impact Analysis
    13.9. Country Level Analysis and Forecast
        13.9.1. Brazil Market Analysis
            13.9.1.1. Introduction
            13.9.1.2. Market Analysis and Forecast by Market Taxonomy
                13.9.1.2.1. By Service Type
                13.9.1.2.2. By Indication
                13.9.1.2.3. By Indication
                13.9.1.2.4. By Phases
        13.9.2. Chile Market Analysis
            13.9.2.1. Introduction
            13.9.2.2. Market Analysis and Forecast by Market Taxonomy
                13.9.2.2.1. By Service Type
                13.9.2.2.2. By Indication
                13.9.2.2.3. By Indication
                13.9.2.2.4. By Phases
14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034
    14.1. Introduction
    14.2. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2023
    14.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
        14.3.1. By Country
            14.3.1.1. China
            14.3.1.2. Japan
            14.3.1.3. South Korea
        14.3.2. By Service Type
        14.3.3. By Indication
        14.3.4. By Indication
        14.3.5. By Phases
    14.4. Market Attractiveness Analysis
        14.4.1. By Country
        14.4.2. By Service Type
        14.4.3. By Indication
        14.4.4. By Therapy
        14.4.5. By Phases
    14.5. Country Level Analysis and Forecast
        14.5.1. China Market Analysis
            14.5.1.1. Introduction
            14.5.1.2. Market Analysis and Forecast by Market Taxonomy
                14.5.1.2.1. By Service Type
                14.5.1.2.2. By Indication
                14.5.1.2.3. By Therapy
                14.5.1.2.4. By Phases
        14.5.2. Japan Market Analysis
            14.5.2.1. Introduction
            14.5.2.2. Market Analysis and Forecast by Market Taxonomy
                14.5.2.2.1. By Service Type
                14.5.2.2.2. By Indication
                14.5.2.2.3. By Therapy
                14.5.2.2.4. By Phases
        14.5.3. South Korea Market Analysis
            14.5.3.1. Introduction
            14.5.3.2. Market Analysis and Forecast by Market Taxonomy
                14.5.3.2.1. By Service Type
                14.5.3.2.2. By Indication
                14.5.3.2.3. By Therapy
                14.5.3.2.4. By Phases
15. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034
    15.1. Introduction
    15.2. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2023
    15.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
        15.3.1. By Country
            15.3.1.1. India
            15.3.1.2. Association of Southeast Asian Nations Countries
            15.3.1.3. Australia and New Zealand
            15.3.1.4. Rest of South Asia and Pacific
        15.3.2. By Service Type
        15.3.3. By Indication
        15.3.4. By Therapy
        15.3.5. By Phases
    15.4. Market Attractiveness Analysis
        15.4.1. By Country
        15.4.2. By Service Type
        15.4.3. By Indication
        15.4.4. By Therapy
        15.4.5. By Phases
    15.5. Country Level Analysis and Forecast
        15.5.1. India Market Analysis
            15.5.1.1. Introduction
            15.5.1.2. Market Analysis and Forecast by Market Taxonomy
                15.5.1.2.1. By Service Type
                15.5.1.2.2. By Indication
                15.5.1.2.3. By Therapy
                15.5.1.2.4. By Phases
        15.5.2. Association of Southeast Asian Nations Countries Market Analysis
            15.5.2.1. Introduction
            15.5.2.2. Market Analysis and Forecast by Market Taxonomy
                15.5.2.2.1. By Service Type
                15.5.2.2.2. By Indication
                15.5.2.2.3. By Therapy
                15.5.2.2.4. By Phases
        15.5.3. Australia and New Zealand Market Analysis
            15.5.3.1. Introduction
            15.5.3.2. Market Analysis and Forecast by Market Taxonomy
                15.5.3.2.1. By Service Type
                15.5.3.2.2. By Indication
                15.5.3.2.3. By Therapy
                15.5.3.2.4. By Phases
16. Western Europe Market 2019 to 2023 and Forecast 2024 to 2034
    16.1. Introduction
    16.2. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2023
    16.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
        16.3.1. By Country
            16.3.1.1. Germany
            16.3.1.2. Italy
            16.3.1.3. France
            16.3.1.4. United States
            16.3.1.5. Spain
            16.3.1.6. BENELUX
            16.3.1.7. Rest of Western Europe
        16.3.2. By Service Type
        16.3.3. By Indication
        16.3.4. By Therapy
        16.3.5. By Phases
    16.4. Market Attractiveness Analysis
        16.4.1. By Country
        16.4.2. By Service Type
        16.4.3. By Indication
        16.4.4. By Therapy
        16.4.5. By Phases
    16.5. Country Level Analysis and Forecast
        16.5.1. Germany Market Analysis
            16.5.1.1. Introduction
            16.5.1.2. Market Analysis and Forecast by Market Taxonomy
                16.5.1.2.1. By Service Type
                16.5.1.2.2. By Indication
                16.5.1.2.3. By Therapy
                16.5.1.2.4. By Phases
        16.5.2. France Market Analysis
            16.5.2.1. Introduction
            16.5.2.2. Market Analysis and Forecast by Market Taxonomy
                16.5.2.2.1. By Service Type
                16.5.2.2.2. By Indication
                16.5.2.2.3. By Therapy
                16.5.2.2.4. By Phases
        16.5.3. Spain Market Analysis
            16.5.3.1. Introduction
            16.5.3.2. Market Analysis and Forecast by Market Taxonomy
                16.5.3.2.1. By Service Type
                16.5.3.2.2. By Indication
                16.5.3.2.3. By Therapy
                16.5.3.2.4. By Phases
        16.5.4. Italy Market Analysis
            16.5.4.1. Introduction
            16.5.4.2. Market Analysis and Forecast by Market Taxonomy
                16.5.4.2.1. By Service Type
                16.5.4.2.2. By Indication
                16.5.4.2.3. By Therapy
                16.5.4.2.4. By Phases
        16.5.5. BENELUX Market Analysis
            16.5.5.1. Introduction
            16.5.5.2. Market Analysis and Forecast by Market Taxonomy
                16.5.5.2.1. By Service Type
                16.5.5.2.2. By Indication
                16.5.5.2.3. By Therapy
                16.5.5.2.4. By Phases
        16.5.6. United Kingdom Market Analysis
            16.5.6.1. Introduction
            16.5.6.2. Market Analysis and Forecast by Market Taxonomy
                16.5.6.2.1. By Service Type
                16.5.6.2.2. By Indication
                16.5.6.2.3. By Therapy
                16.5.6.2.4. By Phases
17. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034
    17.1. Introduction
    17.2. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2023
    17.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
        17.3.1. By Country
            17.3.1.1. Russia
            17.3.1.2. Hungary
            17.3.1.3. Poland
            17.3.1.4. Rest of Eastern Europe
        17.3.2. By Service Type
        17.3.3. By Indication
        17.3.4. By Therapy
        17.3.5. By Phases
    17.4. Market Attractiveness Analysis
        17.4.1. By Country
        17.4.2. By Service Type
        17.4.3. By Indication
        17.4.4. By Therapy
        17.4.5. By Indication
        17.4.6. By Phases
    17.5. Country Level Analysis and Forecast
        17.5.1. Russia Market Analysis
            17.5.1.1. Introduction
            17.5.1.2. Market Analysis and Forecast by Market Taxonomy
                17.5.1.2.1. By Service Type
                17.5.1.2.2. By Indication
                17.5.1.2.3. By Therapy
                17.5.1.2.4. By Phases
        17.5.2. Hungary Market Analysis
            17.5.2.1. Introduction
            17.5.2.2. Market Analysis and Forecast by Market Taxonomy
                17.5.2.2.1. By Service Type
                17.5.2.2.2. By Indication
                17.5.2.2.3. By Therapy
                17.5.2.2.4. By Phases
        17.5.3. Poland Market Analysis
            17.5.3.1. Introduction
            17.5.3.2. Market Analysis and Forecast by Market Taxonomy
                17.5.3.2.1. By Service Type
                17.5.3.2.2. By Indication
                17.5.3.2.3. By Therapy
                17.5.3.2.4. By Phases
18. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034
    18.1. Introduction
    18.2. Key Players Analyzed
    18.3. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2023
    18.4. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
        18.4.1. By Country
            18.4.1.1. Saudi Arabia
            18.4.1.2. Türkiye
            18.4.1.3. South Africa
            18.4.1.4. North Africa
            18.4.1.5. Rest of Middle East and Africa
        18.4.2. By Service Type
        18.4.3. By Indication
        18.4.4. By Therapy
        18.4.5. By Phases
    18.5. Market Attractiveness Analysis
        18.5.1. By Country
        18.5.2. By Service Type
        18.5.3. By Indication
        18.5.4. By Therapy
        18.5.5. By Indication
        18.5.6. By Phases
    18.6. Country Level Analysis and Forecast
        18.6.1. Saudi Arabia Market Analysis
            18.6.1.1. Introduction
            18.6.1.2. Market Analysis and Forecast by Market Taxonomy
                18.6.1.2.1. By Service Type
                18.6.1.2.2. By Indication
                18.6.1.2.3. By Therapy
                18.6.1.2.4. By Phases
        18.6.2. Türkiye Market Analysis
            18.6.2.1. Introduction
            18.6.2.2. Market Analysis and Forecast by Market Taxonomy
                18.6.2.2.1. By Service Type
                18.6.2.2.2. By Indication
                18.6.2.2.3. By Therapy
                18.6.2.2.4. By Phases
        18.6.3. South Africa Market Analysis
            18.6.3.1. Introduction
            18.6.3.2. Market Analysis and Forecast by Market Taxonomy
                18.6.3.2.1. By Service Type
                18.6.3.2.2. By Indication
                18.6.3.2.3. By Therapy
                18.6.3.2.4. By Phases
        18.6.4. North Africa Market Analysis
            18.6.4.1. Introduction
            18.6.4.2. Market Analysis and Forecast by Market Taxonomy
                18.6.4.2.1. By Service Type
                18.6.4.2.2. By Indication
                18.6.4.2.3. By Therapy
                18.6.4.2.4. By Phases
19. Market Structure Analysis
    19.1. Market Analysis by Tier of Companies
    19.2. Market Share Analysis of Top Companies
    19.3. Market Presence Analysis
20. Competition Analysis
    20.1. Competition Benchmarking
    20.2. Competition Dashboard
    20.3. Key Development Analysis
    20.4. Key Promotional Strategies, By Manufacturers
    20.5. Competition Deep Dive
        20.5.1. Charles River Laboratories International, Inc.
            20.5.1.1. Overview
            20.5.1.2. Service Portfolio
            20.5.1.3. Sales Footprint
            20.5.1.4. Key Financials
            20.5.1.5. Key Developments
            20.5.1.6. Strategy Overview
            20.5.1.7. SWOT Analysis
        20.5.2. Catalent, Inc.
        20.5.3. QuintilesIMS (IQVIA)
        20.5.4. Parexel International Corporation
        20.5.5. ICON plc
        20.5.6. PPD, Inc. (Thermo Fisher Scientific)
        20.5.7. LabCorp (Laboratory Corporation of America Holdings)
        20.5.8. Syneos Health
        20.5.9. WuXi AppTec
        20.5.10. Lonza Group
        20.5.11. Piramal Pharma Solutions
        20.5.12. SGS SA
        20.5.13. Evotec SE
        20.5.14. CMC Biologics (Now AGC Biologics)
        20.5.15. Marken (A UPS Company)
        20.5.16. Cytovance Biologics
        20.5.17. Samsung Biologics
        20.5.18. CordenPharma
        20.5.19. Recipharm AB
        20.5.20. Vetter Pharma International GmbH
        20.5.21. Cryoport Systems, Inc.
        20.5.22. ProPharma Group
        20.5.23. Fujifilm Diosynth Biotechnologies
        20.5.24. Medpace
        20.5.25. Novotech Pty Ltd.
        20.5.26. Axcella Health Inc.
        20.5.27. Celerion
21. Assumptions and Acronyms Used
22. Research Methodology